THURSDAY, March 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

The following is a summary of “Reducing time delays and enhancing reperfusion eligibility related to stroke suspicion by the ...

Brazilian researchers have developed a cell phone application that helps rehabilitate people who have suffered a stroke.

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Chronic stress can increase young women's risk of stroke, a new study says. Moderate stress increases risk of stroke by 78% ...

The ambulance would be the latest addition to Florida’s first mobile stroke treatment unit network, which speeds care to ...

TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...

Blood test likened to a lateral flow test used to detect Covid is being piloted by ambulance crews in Cambridgeshire ...

NHS pressures and “deep inequalities in care” are “failing” stroke patients, according to a report. The Stroke Association ...

Music therapy can help lift the spirits and ease depression in people with dementia, a new evidence review has found.